R
Radiopharm Theranostics Ltd
ASX:RAD
Radiopharm Theranostics Ltd
ASX:RAD
Price:
0.022
AUD
-4.35%
Market Closed
Market Cap:
AU$61.2m
Income Statement
Earnings Waterfall
Radiopharm Theranostics Ltd
Radiopharm Theranostics Ltd
Income Statement
Radiopharm Theranostics Ltd
Radiopharm Theranostics Ltd
Currency: AUD
| Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|
| Revenue | ||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
2
+462%
|
4
+116%
|
|
| Gross Profit | ||||||
| Cost of Revenue |
0
|
0
|
0
|
(2)
|
(4)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
0
N/A
|
|
| Operating Income | ||||||
| Operating Expenses |
(35)
|
(41)
|
(37)
|
(38)
|
(34)
|
|
| Selling, General & Administrative |
(15)
|
(16)
|
(16)
|
(15)
|
(17)
|
|
| Research & Development |
(22)
|
(31)
|
(20)
|
(22)
|
(25)
|
|
| Depreciation & Amortization |
(3)
|
0
|
(3)
|
0
|
(3)
|
|
| Other Operating Expenses |
6
|
6
|
1
|
(2)
|
10
|
|
| Operating Income |
(34)
N/A
|
(41)
-20%
|
(37)
+10%
|
(38)
-2%
|
(34)
+11%
|
|
| Pre-Tax Income | ||||||
| Interest Income Expense |
(0)
|
(6)
|
(11)
|
(4)
|
(4)
|
|
| Pre-Tax Income |
(35)
N/A
|
(47)
-35%
|
(48)
-2%
|
(43)
+11%
|
(38)
+10%
|
|
| Net Income | ||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(35)
|
(47)
|
(48)
|
(43)
|
(38)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
1
|
2
|
|
| Net Income (Common) |
(35)
N/A
|
(47)
-35%
|
(48)
-2%
|
(43)
+11%
|
(38)
+10%
|
|
| EPS (Diluted) |
-0.11
N/A
|
-0.13
-18%
|
-0.12
+8%
|
-0.02
+83%
|
-0.02
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
